A preliminary evaluation of a novel method to monitor a triple antioxidant combination (vitamins E, C and α-lipoic acid) in diabetic volunteers using in vitro methaemoglobin formation

Environmental Toxicology and Pharmacology

Volumn 14, Issue 1-2, 2003, Pages 69-75

  Coleman, Michael D ^a   Fernandes, Sandra ^a   Khanderia, Leena ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Dapsone hydroxylamine; Human; Methaemoglobin; Vitamins C and E; Lipoic acid

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; DIHYDROLIPOATE; FRUCTOSAMINE; GLUTATHIONE; GLYCOSYLATED HEMOGLOBIN; METHEMOGLOBIN; N HYDROXYDAPSONE; THIOCTIC ACID; THIOL;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ASSAY; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPLETION; DIABETES MELLITUS; DRUG EFFICACY; ERYTHROCYTE; FEMALE; FRUCTOSAMINE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HEMOGLOBIN SYNTHESIS; HUMAN; IN VITRO STUDY; LABORATORY TEST; MALE; METABOLISM; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SUPPLEMENTATION; TECHNIQUE; TREATMENT OUTCOME;

EID: 12444264864     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(03)00027-9     Document Type: Article

References (36)

1. Anderson M.E. Determination of GSH and GSH disulfide in biological samples. Methods Enzymol. 113:1985;548.
2. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405.
3. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications a new perspective on an old paradigm. Diabetes. 48:1999;1.
4. Biewenga G.P., Haenen G.R.R.M., Bast A. The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 29:1997;315.
5. Blakynty R., Harding J.J. Glycation (non-enzymatic glycosylation) inactivates glutathione reductase. Biochem. J. 288:1992;303.
6. Blostein-Fujii A., DiSilvestro R.A., Frid D., Katz C. Short term citrus flavonoid supplimentation of type II diabetic women: no effect on lipoprotein oxidation tendencies. Free Radic. Res. 30:1999;315.
7. Borcea V., Nourooz-Zadeh J., Wolff S.P., Klevesath M., Hofmann M., Urich H., Wahl P., Ziegler R., Tritschler H.J., Halliwell B., Nawroth P.P. Alpha-lipoic acid decreases oxidative stress even in diabetic patients with poor glycaemic control and albuminuria. Free Radic. Biol. Med. 26:1999;1495.
8. Bunn H.F., Higgins P.J. Reaction of monosaccharides with proteins-possible evolutionary significance. Science. 213:1981;222.
9. Ceriello A., Bortolotti N., Motz E., Lizzio S., Catone B., Assaloni R., Tonutti L., Taboga C. Red wine protects diabetic patients from meal induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes. Eur. J. Clin. Invest. 31:2001;322.
10. Coleman M.D. 'Commentary' the use of in vitro methaemoglobin generation to study antioxidant status in the diabetic erythrocyte. Biochem. Pharmacol. 60:2000;1409.
11. Coleman M.D. Editorial: 'antioxidants: unlocking their potential'. Environ. Toxicol. Pharmacol. 10:2001;139a.
12. Coleman M.D. Monitoring diabetic antioxidant status: a role of in vitro methaemoglobin formation. Environ. Toxicol. Pharmacol. 10:2001;207.
13. Coleman M.D., Baker C.D. Effects if the antioxidants dihydrolipoic acid and probucol on xenobiotic-mediated methaemoglobin formation in human diabetic and non-diabetic erythrocytes in vitro. Environ. Toxicol. Pharmacol. 9:2001;161.
14. Coleman M.D., Walker C.L. Effects of the antioxidants α-lipoic acid and α-tocopherol on xenobiotic-mediated methaemoglobin formation in human diabetic and non-diabetic erythrocytes in vitro. Environ. Toxicol. Pharmacol. 8:2000;127.
15. Coleman M.D., Jacobus D.P. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. Biochem. Pharmacol. 45:1993;1027.
16. Coleman M.D., Simpson J., Jacobus D.P. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. III: effect of type I diabetes. Biochem. Pharmacol. 48:1994;1341.
17. Coleman M.D., Ogg M.S., Holmes J.L., Gardiner J.M., Jacobus D.P. Studies on the differential sensitivity between diabetic and non-diabetic human erythrocytes to monoacetyl dapsone hydroxylamine-mediated methaemoglobin formation in vitro. Environ. Toxicol. Pharmacol. 1:1996;97.
18. Coleman M.D., Hayes P.J., Jacobus D.P. Methaemoglobin formation due to nitrite, disulfiram, 4-aminophenol and monoacetyldapsone hydroxylamine in diabetic and non-diabetic human erythrocytes in vitro. Environ. Toxicol. Pharmacol. 5:1998;61.
19. Coleman M.D., Eason R.C., Bailey C.J. The therapeutic use of lipoic acid in diabetes: a current perspective. Environ. Toxicol. Pharmacol. 10:2001;167.
20. Coleman M.D., Tolley H.L., Desai A.K. Monitoring antioxidant effects using methaemoglobin formation in diabetic erythrocytes. Br. J. Diab. Vas. Dis. 1:2001;88.
21. Di Simplicio P., De Georgio L.A., Cardaioli E., Lecis K., Miceli M., Rossi R., Anichini R., Mian R., Seghieri G., Franconi F. Glutathione, glutathione utilizing enzymes and thioltransferase in platelets of insulin-dependent diabetic patients: relation with platelte aggregation and microangiopatic complications. Eur. J. Clin. Invest. 25:1995;665.
22. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial. New Engl. J. Med. 329:1993;977.
23. Engelen W., Keenoy B.M.Y., Vertommen J., De Leeuw I. Effects of long-term supplementation with moderate pharmacological doses of vitamin E are saturable and reversible in patients with Type 1 diabetes. Am. J. Clin. Nutr. 72:2000;1142.
24. Heilmair R., Karreth S., Lenk W. The metabolism of 4-aminobiphenyl in the rat II. Reaction of 4-hydroxy-4-aminobiphenyl with rat blood in vitro. Xenobiotica. 21:1991;805.
25. Keenoy B.M.Y., Vertommen J., De Leeuw I. The effect of flavonoid treatment on the glycation and antioxidant status in Type I diabetic patients. Diab. Nutr. Metab. 12:1999;256.
26. Kiese M. The biochemical production of ferrihemoglobin-forming derivatives from aromatic amines, and mechanisms of ferrihemoglobin formation. Pharmacol. Rev. 18:1966;1091.
27. Kramer P.A., Glader B.E., Li T.K. Mechanism of methaemoglobin formation by diphenylsulphones. Biochem. Pharmacol. 21:1972;1265.
28. Miller N.J., Rice-Evans C., Davie M.J., Gopinathan V., Milner A. A novel method for measuring antioxidant capacity and its application for monitoring the antioxidant status in premature neonates. Clin. Sci. 84:1993;407.
29. Nathan D.M., Meigs J., Singer D.E. The epidermology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is ... or is it. Lancet. 350:1997;4.
30. Scott G.L., Rasbridge M.R. The in vitro action of dapsone and its derivatives on normal and G6PD-deficient red cells. Br. J. Haematol. 24:1973;307.
31. Seghrouchni I., Drai J., Bannier E., Riviere J., Calmard P., Garcia I., Orgiazzi J., Revol A. Oxidative stress parameters in type I, type II and insulin-treated type-2 diabetes mellitus; insulin treatment efficiency. Clin. Chim. Acta. 321:2002;89.
32. Skyler J. Diabetic complications: the importance of glucose control. Brownlee M.B., King G.L. Endocrinology and Metabolism. 1996 Clinics of North America. 1996;WB Saunders.
33. Stratton I.M., Adler A., Neil H.A.W., Matthews D., Manely S., Cull A.C., Hadden D., Turner R.C., Holman R.R. Association of glycaemia with microvascular and microvascular complications of type 2 diabetes (UKPDS 35): a prospective observational study. Br. Med. J. 321:2000;405.
34. Ting H.H., Timimi F.K., Boles K.S., Creager S.J., Ganz P., Creager M.A. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 97:1996;22.
35. Wautier J.L., Wautier M.P., Anderson G.M., Hori O., Zoukourian C., Capron L., Chappey O., Yan S.D., Brett J., Guillausseau P.J., Stern D. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc. Natl. Acad. Sci. USA. 91:1994;9441.
36. Yoshida K., Hirokawa J., Tagami S.S., Kawakami Y., Urata Y., Kondo T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia. 38:1995;201.